Biocon Limited ( (IN:BIOCON)) just unveiled an update. Biocon Limited has increased its ownership in its unlisted material subsidiary, Biocon Biologics Limited (BBL), to around 94% of BBL’s fully ...

Stock market today: The Indian stock market remained under bearish pressure as the benchmark Sensex plunged another 800 ...

Biocon earns USFDA nod for Liraglutide injection, boosting its diabetes drug portfolio. Explore investment opportunities now!

The market is expected to see consolidation with range-bound trading in the next few sessions. Below are some short-term trading ideas to consider.

Stocks of Indian Renewable Energy Development Agency Ltd., Max Financial Services Ltd., Tata Steel Ltd., Biocon Ltd. and ...

I write about Asia's richest, fast-growing businesses, and startups. Biocon—controlled by Indian pharmaceutical billionaire Kiran Mazumdar-Shaw—is buying the rest of privately held subsidiary Biocon ...

Biocon Biologics is among the leading global suppliers of biosimilar insulins and has been expanding its portfolio ...

HYDERABAD, Jan 31 (Reuters) - Indian biopharmaceutical firm Biocon (BION.NS), opens new tab is likely to list its key biosimilars business by March 2026 and aims for double-digit share in its core U.S ...

Stocks in news often attract significant attention from traders and investors as corporate developments, sector trends, and ...

Biocon Limited on Tuesday received USFDA approval for its generic version of Liraglutide Injection (18 mg/3 mL), a GLP-1 weight management drug sold under the brand name Saxenda, marking the company’s ...